valine has been researched along with Blood Clot in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 4 (44.44) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, F; Chen, XN; Jiang, MH; Shen, WF; Wang, HY; Wang, LJ; Wang, XF; Wu, F; Yang, Q; Zhang, FR | 1 |
Ziakas, PD | 1 |
Bové, A; Cervera, R; de la Red, G; Espinosa, G; Monteagudo, J; Plaza, J; Reverter, JC; Tàssies, D | 1 |
Antoniades, C; Kardara, D; Koumallos, N; Kyvelou, SM; Papageorgiou, N; Stefanadis, C; Tousoulis, D; Vasiliadou, C; Vlachopoulos, C; Xaplanteris, P | 1 |
Iványi, JL; Marton, E; Plander, M | 1 |
Choi, SJ; Ji, JD; Lee, YH; Song, GG | 1 |
Fujimoto, H; Gotoh, A; Ito, Y; Kiguchi, T; Kimura, Y; Miyazawa, K; Ohyashiki, JH; Ohyashiki, K; Tauchi, T | 1 |
Bovill, EG; Long, GL; Lu, D | 1 |
Casado, S; Gómez, J; Jiménez, A; Lopez-Bloya, A; López-Farré, A; Montón, M; Núñez, A; Rico, L; Sánchez de Miguel, L | 1 |
2 review(s) available for valine and Blood Clot
Article | Year |
---|---|
Association between the valine/leucine247 polymorphism of β2-glycoprotein I and susceptibility to anti-phospholipid syndrome: a meta-analysis.
Topics: Alleles; Antibodies; Antiphospholipid Syndrome; beta 2-Glycoprotein I; Genetic Predisposition to Disease; Humans; Leucine; Polymorphism, Genetic; Thrombosis; Valine | 2012 |
Angiotensin II AT(1) receptor antagonists and platelet activation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Coronary Disease; Coronary Thrombosis; Humans; Losartan; P-Selectin; Platelet Activation; Platelet Aggregation; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Thromboxane; Tetrazoles; Thrombosis; Thromboxane A2; Valine; Valsartan | 2001 |
1 trial(s) available for valine and Blood Clot
Article | Year |
---|---|
Valsartan decreases platelet activity and arterial thrombotic events in elderly patients with hypertension.
Topics: Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Blood Platelets; Blotting, Western; Cell Line; Cyclooxygenase 2; Female; Humans; Hypertension; Male; Platelet Aggregation; Real-Time Polymerase Chain Reaction; Tetrazoles; Thrombosis; Thromboxane B2; Valine; Valsartan | 2015 |
6 other study(ies) available for valine and Blood Clot
Article | Year |
---|---|
Effect of JAK2 V617F on thrombotic risk in patients with essential thrombocythemia: measuring the uncertain.
Topics: Humans; Janus Kinase 2; Phenylalanine; Risk Factors; Thrombocythemia, Essential; Thrombocytosis; Thrombosis; Uncertainty; Valine | 2008 |
Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels.
Topics: Adult; Antiphospholipid Syndrome; Case-Control Studies; Factor XIII; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Humans; Leucine; Male; Odds Ratio; Polymorphism, Genetic; Protein Subunits; Risk Assessment; Risk Factors; Thrombosis; Up-Regulation; Valine | 2009 |
Effects of the Ala379Val polymorphism of lipoprotein-associated phospholipase A2 on thrombosis and inflammation in hypertensive patients.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Alanine; Fibrinogen; Gene Frequency; Genotype; Heterozygote; Humans; Hypertension; Inflammation; Logistic Models; Male; Middle Aged; Polymorphism, Single Nucleotide; Thrombosis; Valine | 2011 |
[Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
Topics: Adult; Aged; Bone Marrow Neoplasms; Chronic Disease; Female; Humans; Janus Kinase 2; Male; Middle Aged; Mutation; Myeloproliferative Disorders; Phenylalanine; Polycythemia Vera; Polymerase Chain Reaction; Predictive Value of Tests; Primary Myelofibrosis; Retrospective Studies; Signal Transduction; Thrombocythemia, Essential; Thrombosis; Valine | 2011 |
Leukocytosis is linked to thrombosis at diagnosis, while JAK2 V617F mutation is associated with thrombosis during the course of essential thrombocythemia.
Topics: Aged; Female; Humans; Janus Kinase 2; Leukocytosis; Male; Middle Aged; Mutation; Phenylalanine; Thrombocythemia, Essential; Thrombosis; Valine | 2008 |
Molecular mechanism for familial protein C deficiency and thrombosis in protein CVermont (Glu20-->Ala and Val34-->Met).
Topics: Alanine; Base Sequence; DNA Primers; Glutamic Acid; Humans; Methionine; Molecular Sequence Data; Mutagenesis, Site-Directed; Protein C; Protein C Deficiency; Thrombosis; Valine | 1994 |